Sammeli Liikkanen, PhD, eMBA, is founder of PalsaIQ, an AI and digital transformation consultancy for life sciences, and CEO of Dianome, a Finnish genomic medicine company translating tumour sequencing into treatment guidance. He spent over two decades at Orion Pharma, most recently as Director of Digital Medicine and earlier as Chief Digital Officer and Head of X Lab, leading data platforms, AI/ML, bioinformatics, digital biomarkers and digital therapeutics across R&D, and heading a government-backed pharmaceutical research ecosystem. He serves as a member of the Strategic Research Council at the Research Council of Finland, and advises several health and AI companies.